Company News, Financial News

J&J Releases Q2 Results

COVID-19 impacts consumer health unit performance.

Johnson & Johnson today announced results for second-quarter 2020, with consumer health unit sales—home to Neutrogena and Aveeno—falling 3.4% to  $3.296 billion.    Consumer health worldwide operational sales, excluding the net impact of acquisitions and divestitures, declined by 3.4% as results were negatively impacted by the COVID-19 pandemic most notably reflected in skin health and beauty care products, followed by women's health care products and international baby care products...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters